T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cooper Companies
COO
$15B
| $698M | 0.15% |
17,230,364
-642,568
| -4% | -$25.8M |
|
177
Xylem
XYL
$28.8B
| $694M | 0.15% |
18,230,619
+991,210
| +6% | +$36.3M |
|
178
Franco-Nevada
FNV
$46.4B
| $690M | 0.15% |
13,971,008
+707,870
| +5% | +$36M |
|
179
Emerson Electric
EMR
$91.7B
| $690M | 0.15% |
11,175,553
+721,030
| +7% | +$45.2M |
|
180
Norwegian Cruise Line
NCLH
$8.59B
| $689M | 0.15% |
14,734,616
+2,003,053
| +16% | +$80.4M |
|
181
Bunge Global
BG
$21.4B
| $685M | 0.15% |
7,539,941
+176,655
| +2% | +$15.5M |
|
182
American Electric Power
AEP
$67.3B
| $679M | 0.14% |
11,175,273
+685,640
| +7% | +$39.2M |
|
183
Gartner
IT
$11.8B
| $677M | 0.14% |
8,039,310
-447,834
| -5% | -$36.4M |
|
184
VeriSign
VRSN
$26B
| $676M | 0.14% |
11,853,849
-473,990
| -4% | -$27.4M |
|
185
Idexx Laboratories
IDXX
$46.2B
| $659M | 0.14% |
8,891,162
-2,956,044
| -25% | -$207M |
|
|
APC
186
DELISTED
Anadarko Petroleum
APC
| $658M | 0.14% |
7,970,274
-2,895,748
| -27% | -$252M |
|
187
Elevance Health
ELV
$84.7B
| $656M | 0.14% |
5,222,754
+306,508
| +6% | +$37.9M |
|
188
Martin Marietta Materials
MLM
$33.3B
| $645M | 0.14% |
5,849,636
-545,670
| -9% | -$64.5M |
|
189
Factset
FDS
$10.1B
| $642M | 0.14% |
4,563,606
-530,656
| -10% | -$70.5M |
|
190
Sensata Technologies
ST
$6.73B
| $639M | 0.14% |
12,191,376
+810,788
| +7% | +$39.3M |
|
|
RDS.B
191
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $620M | 0.13% |
8,917,187
+692,226
| +8% | +$49.9M |
|
|
WP
192
DELISTED
Worldpay, Inc.
WP
| $616M | 0.13% |
18,150,795
+1,177,915
| +7% | +$38.1M |
|
193
Pentair
PNR
$10.7B
| $614M | 0.13% |
13,762,292
+9,096,210
| +195% | +$399M |
|
194
Walmart Inc
WMT
$901B
| $613M | 0.13% |
21,418,914
+4,166,748
| +24% | +$113M |
|
195
Berkshire Hathaway Class B
BRK.B
$1.11T
| $611M | 0.13% |
4,068,704
-25,930
| -0.6% | -$3.74M |
|
196
Progressive
PGR
$123B
| $609M | 0.13% |
22,547,096
-350,440
| -2% | -$9.24M |
|
|
STI
197
DELISTED
SunTrust Banks, Inc.
STI
| $607M | 0.13% |
14,489,852
-305,700
| -2% | -$12M |
|
198
Abbott
ABT
$190B
| $604M | 0.13% |
13,423,664
+3,652,595
| +37% | +$159M |
|
199
Verisk Analytics
VRSK
$23.6B
| $598M | 0.13% |
9,332,272
+911,999
| +11% | +$56.8M |
|
|
200
Keysight
KEYS
$58.7B
| $593M | 0.13% |
+17,553,953
| New | +$573M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.